On December 6, 2023 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reported that it will host its Investor and Analyst Day on Tuesday, December 12, 2023 (Press release, Ligand, DEC 6, 2023, View Source [SID1234638194]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Members of Ligand’s senior management team will provide an update on the company’s strategy and portfolio as well as a multi-year financial outlook and a 2024 guidance preview. The in-person event will be held at the Harvard Club in New York City from 10:30am – 12:00pm. Analysts and investors may register for the event by clicking here. A live and archived webcast will also be available for those unable to attend in person at investor.ligand.com/.

Presenters will include:

Todd Davis, Chief Executive Officer
Matt Korenberg, President and Chief Operating Officer
Tavo Espinoza, Chief Financial Officer
Paul Hadden, Senior Vice President, Investments and Business Development
Lauren Hay, Vice President, Strategic Planning and Investment Analytics